Shuang T - Search Results

1

Targeted delivery of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization.

Zhao Z, Shuang T, Gao Y, Lu F, Zhang J, He W, Qu L, Chen B, Hao Q. Zhao Z, et al. Among authors: shuang t. Cancer Lett. 2022 Apr 1;530:45-58. doi: 10.1016/j.canlet.2022.01.011. Epub 2022 Jan 18. Cancer Lett. 2022. PMID: 35051533

2

Up-Regulation of Long Noncoding RNA SRA Promotes Cell Growth, Inhibits Cell Apoptosis, and Induces Secretion of Estradiol and Progesterone in Ovarian Granular Cells of Mice.

Li Y, Wang H, Zhou D, Shuang T, Zhao H, Chen B. Li Y, et al. Among authors: shuang t. Med Sci Monit. 2018 Apr 20;24:2384-2390. doi: 10.12659/msm.907138. Med Sci Monit. 2018. PMID: 29674607 Free PMC article.

3

Down-regulated expression of miR-134 contributes to paclitaxel resistance in human ovarian cancer cells.

Shuang T, Wang M, Shi C, Zhou Y, Wang D. Shuang T, et al. FEBS Lett. 2015 Oct 7;589(20 Pt B):3154-64. doi: 10.1016/j.febslet.2015.08.047. Epub 2015 Sep 9. FEBS Lett. 2015. PMID: 26363097 Free article.

4

Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer.

Pei ML, Zhao ZX, Shuang T. Pei ML, et al. Among authors: shuang t. J Ovarian Res. 2020 Dec 10;13(1):144. doi: 10.1186/s13048-020-00750-4. J Ovarian Res. 2020. PMID: 33302997 Free PMC article.

5

MiR-1307 influences the chemotherapeutic sensitivity in ovarian cancer cells through the regulation of the CIC transcriptional repressor.

Zhou Y, Wang M, Shuang T, Liu Y, Zhang Y, Shi C. Zhou Y, et al. Among authors: shuang t. Pathol Res Pract. 2019 Oct;215(10):152606. doi: 10.1016/j.prp.2019.152606. Epub 2019 Aug 19. Pathol Res Pract. 2019. PMID: 31500928

6

The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer.

Zhou Y, Wang M, Wu J, Jie Z, Chang S, Shuang T. Zhou Y, et al. Among authors: shuang t. J Ovarian Res. 2015 Apr 9;8:23. doi: 10.1186/s13048-015-0143-5. J Ovarian Res. 2015. PMID: 25887170 Free PMC article.

7

NF-κB1, c-Rel, and ELK1 inhibit miR-134 expression leading to TAB1 upregulation in paclitaxel-resistant human ovarian cancer.

Shuang T, Wang M, Zhou Y, Shi C, Wang D. Shuang T, et al. Oncotarget. 2017 Apr 11;8(15):24853-24868. doi: 10.18632/oncotarget.15267. Oncotarget. 2017. PMID: 28206956 Free PMC article.

8

Over-expression of nuclear NF-κB1 and c-Rel correlates with chemoresistance and prognosis of serous epithelial ovarian cancer.

Shuang T, Wang M, Zhou Y, Shi C. Shuang T, et al. Exp Mol Pathol. 2016 Feb;100(1):139-44. doi: 10.1016/j.yexmp.2015.11.030. Epub 2015 Dec 9. Exp Mol Pathol. 2016. PMID: 26683819

9

Hybrid-polymerase chain reaction to identify novel target genes of miR-134 in paclitaxel resistant human ovarian carcinoma cells.

Shuang T, Wang M, Chang S. Shuang T, et al. Oncol Lett. 2015 Jun;9(6):2910-2916. doi: 10.3892/ol.2015.3137. Epub 2015 Apr 23. Oncol Lett. 2015. PMID: 26137169 Free PMC article.

10

Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC).

Shuang T, Wang M, Zhou Y, Shi C. Shuang T, et al. Med Oncol. 2015 Dec;32(12):260. doi: 10.1007/s12032-015-0706-8. Epub 2015 Oct 31. Med Oncol. 2015. PMID: 26520143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters